- Home
- TENB vs HTFL Comparison
TENB vs HTFL Comparison
Compare TENB & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TENB | HTFL |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | 1872 | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | TENB | HTFL |
|---|---|---|
| Price | $24.17 | $30.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | $39.25 | ★ $39.50 |
| AVG Volume (30 Days) | ★ 1.5M | 738.8K |
| Earning Date | 02-04-2026 | 02-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $974,603,000.00 | $161,881,000.00 |
| Revenue This Year | $12.22 | $40.42 |
| Revenue Next Year | $7.62 | $22.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 11.05 | ★ 85.70 |
| 52 Week Low | $23.97 | $25.38 |
| 52 Week High | $45.45 | $41.22 |
Technical Indicators
Market Signals| Indicator | TENB | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 28.92 | N/A |
| Support Level | $23.97 | N/A |
| Resistance Level | $25.18 | N/A |
| Average True Range (ATR) | 0.63 | 0.00 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 6.12 | 0.00 |
Price Performance
Historical ComparisonAbout TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.